← Back to Search

Individuals receiving conduction system pacing for Bradyarrhythmias

N/A
Recruiting
Led By Roderick Tung, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Meets American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Rhythm Society (HRS) guidelines for bradycardia, or * Meets ACC/AHA/HRS guidelines for cardiac resynchronization therapy (CRT).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 12 months
Awards & highlights

Summary

The purpose of this registry study is to collect information about routine clinical practices with device implantation to treat bradycardia and cardiac systolic dysfunction (heart rhythm disorders) across global centers of excellence in cardiac pacing. In particular, this study will examine the use of conduction system pacing (CSP) in clinical practice. Information collected in the registry will help researchers better characterize strengths and limitations of current technology and treatments.

Eligible Conditions
  • Bradyarrhythmias
  • Heart Failure

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Any-cause mortalities
Changes in chamber dimension
Changes in left ventricular ejection fraction
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Individuals receiving conduction system pacingExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Biotronik SE & Co. KGIndustry Sponsor
111 Previous Clinical Trials
46,871 Total Patients Enrolled
University of ChicagoLead Sponsor
1,036 Previous Clinical Trials
757,729 Total Patients Enrolled
Roderick Tung, MDPrincipal InvestigatorUniversity of Chicago
5 Previous Clinical Trials
473 Total Patients Enrolled
~128 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top